1[2]Jorda M,Ganjei AP,Nadji M.Cytologic characteristics of meningeal carcinomatosis:increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunoocytochemistry.Arch Neurol,1998,5(2):181-184.
2[4]Lee CT,Fan FS,Chen PM,et al.The application of any immunocytochemistry in diagnosis of meningeal carcinomatosis in a patient with unkonown primary site.Chung Hua I Huseh Chih Tiapei,1992,50(7):429-433.
4[6]Castro MP,Mc Donald TJ,Qualman SJ,et al.Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma.Cancer,2001,91(11):2 122-2 126.
5Jorda M,Ganjei Azarp,Nadji M. Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry[J]. Arch Neurol,1998,55:181.
7Coakham HB,Garson JA,Brownell B,et al. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid[J]. Lancet,1984,19:1095.
8Castro MP,McDonald TJ,Qualman SJ,et al. Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma[J].Cancer,2001,91:2122.
